Refeeding syndrome is associated with increased mortality in malnourished medical inpatients: Secondary analysis of a randomized trial

Autor: Ramona Hummel, Manuela Deiss, Pascal Tribolet, Natalie Friedli, Filomena Gomes, Jonas Odermatt, Susan Felder, Martina Geiser, Philipp Schuetz, Zeno Stanga, Milena Kloter, Rebecca Fehr, Jessica Baumann, Beat Mueller, Valerie Baechli
Rok vydání: 2020
Předmět:
Zdroj: Medicine
Friedli, Natalie; Baumann, Jessica; Hummel, Ramona; Kloter, Milena; Odermatt, Jonas; Fehr, Rebecca; Felder, Susan; Baechli, Valerie; Geiser, Martina; Deiss, Manuela; Tribolet, Pascal; Gomes, Filomena; Mueller, Beat; Stanga, Zeno; Schuetz, Philipp (2020). Refeeding syndrome is associated with increased mortality in malnourished medical inpatients: Secondary analysis of a randomized trial. Medicine, 99(1), e18506. Lippincott Williams & Wilkins 10.1097/MD.0000000000018506
ISSN: 1536-5964
DOI: 10.1097/MD.0000000000018506
Popis: BACKGROUND Whether the occurrence of refeeding syndrome (RFS), a metabolic condition characterized by electrolyte shifts after initiation of nutritional therapy, has a negative impact on clinical outcomes remains ill-defined. We prospectively investigated a subgroup of patients included in a multicentre, nutritional trial (EFFORT) for the occurrence of RFS. METHODS In this secondary analysis of a randomized-controlled trial investigating the effects of nutritional support in malnourished medical inpatients, we prospectively screened patients for RFS and classified them as "RFS confirmed" and "RFS not confirmed" based on predefined criteria (i.e. electrolyte shifts, clinical symptoms, clinical context, and patient history). We assessed associations of RFS and mortality within 180 days (primary endpoint) and other secondary endpoints using multivariable regression analysis. RESULTS Among 967 included patients, RFS was confirmed in 141 (14.6%) patients. Compared to patients with no evidence for RFS, patients with confirmed RFS had significantly increased 180-days mortality rates (42/141 (29.8%) vs 181/826 (21.9%), adjusted odds ratio (OR) 1.53 (95% CI 1.02 to 2.29), P
Databáze: OpenAIRE